NeuroSense Therapeutics Ltd. ( NRSN) - Key Metrics
NRSN Revenue per Share metrics
| Date | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share | |
|---|---|---|---|---|
| 2025Q2 | ? | -$0.09 | $0 | $0 |
| 2025Q1 | ? | -$0.09 | ? | ? |
| 2024Q4 | ? | -$0.08 | ? | ? |
| 2024Q3 | ? | -$0.11 | ? | ? |
| 2024Q2 | ? | -$0.05 | ? | ? |
NRSN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -5.10 |
| 2025Q1 | ? | -2.51 |
| 2024Q4 | ? | -3.61 |
| 2024Q3 | ? | -2.93 |
| 2024Q2 | ? | -5.69 |
NRSN
Price: $0.78
52 week price:
Earnings Per Share: -0.36 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 108700
Market Capitalization: 22.1 million